Food & Beverages Global On demand · 24-48h

Global Vitamin B12 Market Strategic Research Report

Global Vitamin B12 Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Vitamin B12 Market
$4882025
4.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Content 98%, Content 2%, Content 1%, Others

By Application: Feed Industry, Pharmaceutical Industry, Food Industry, Daily Chemicals and Environmental Protection, Cosmetics, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Ouroboros, North China Pharmaceutical Group, Hebei Yufeng, Ningxia Jinwei, Hebei Huarong Pharmaceutical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 74 pages
Market size 2025
$488
Million USD
Forecast CAGR
4.4%
2025-2032
Forecast 2032
$659.7
Projected
Области
5
Asia Pacific · Latin America · MEA · Europe · North America

Обзор

Scope of the Report

The global Vitamin B12 market size is predicted to grow from US$ 488 million in 2025 to US$ 657 million in 2032; it is expected to grow at a CAGR of 4.4% from 2026 to 2032.

Vitamin B12 is a nutrient that helps keep the body's nerve and blood cells healthy and helps make DNA, the genetic material in all cells. Vitamin B12 also helps prevent a type of anemia called megaloblastic anemia that makes people tired and weak.In 2025, global Vitamin B12 production reached approximately 148 MT.

The global vitamin B12 market is growing steadily, driven by a broad expansion in both consumer wellness and clinical nutrition needs. Growth tends to be consistent rather than explosive, reflecting B12’s role as a staple micronutrient that benefits from recurring, long-term consumption patterns. As more brands enter supplements and functional foods, B12 increasingly shows up across a wider range of everyday products, which supports gradual, durable market expansion.

Demand is rising mainly because more people are paying attention to deficiency risk and preventative health—especially among older adults and people who eat little or no animal products. Fortified foods are becoming more common, and supplement formats have diversified (tablets, gummies, liquids, sprays, sublingual forms), helping reach new consumer segments. Clinical usage also contributes, since B12 remains a standard therapy for certain deficiency-related conditions, reinforcing baseline demand regardless of consumer trends.

On the supply side, market growth can be uneven quarter to quarter because B12 production is concentrated among a limited number of fermentation-based manufacturers and the value chain can be sensitive to capacity shifts, quality/regulatory requirements, and logistics. This can create periods where prices tighten or availability fluctuates, prompting buyers to adjust inventories. Even with these short-term swings, the overall direction remains upward as B12 continues to be embedded in global nutrition, healthcare, and fortification programs.

This report presents a comprehensive overview of the global Vitamin B12 market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Content 98%
  • Content 2%
  • Content 1%
  • Others

Segment by Feature

  • Food Grade
  • Feed Grade

Segment by Channel

  • Direct Selling
  • Distribution

Segment by Application

  • Feed Industry
  • Pharmaceutical Industry
  • Food Industry
  • Daily Chemicals and Environmental Protection
  • Cosmetics
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Vitamin B12 market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Feed Industry, Pharmaceutical Industry, Food Industry evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Vitamin B12 Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 4.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$488
2025
Forecast
$659.7
2032
CAGR
4.4%
2025–2032
Области
5
global
Key companies
OuroborosNorth China Pharmaceutical GroupHebei YufengNingxia JinweiHebei Huarong Pharmaceutical
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Content 98%Content 2%Content 1%Others
By Application
Feed IndustryPharmaceutical IndustryFood IndustryDaily Chemicals and Environmental ProtectionCosmeticsOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Content 98%
  • 3.1.3 Content 2%
  • 3.1.4 Content 1%
  • 3.1.5 Others
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Feed Industry
  • 4.1.3 Pharmaceutical Industry
  • 4.1.4 Food Industry
  • 4.1.5 Daily Chemicals and Environmental Protection
  • 4.1.6 Cosmetics
  • 4.1.7 Other
  • 4.1.8 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Ouroboros
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 North China Pharmaceutical Group
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Hebei Yufeng
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Ningxia Jinwei
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Hebei Huarong Pharmaceutical
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Vitamin B12 market size?
The global Vitamin B12 market is estimated at US$ 488 million in 2025 (base year) and is projected to reach US$ 657 million by 2032.
What growth rate is expected for the Vitamin B12 market through 2032?
The market is expected to grow at a CAGR of 4.4% from 2026 to 2032, expanding from US$ 488 million in 2025 to US$ 657 million in 2032, roughly 1.3 times its base-year value.
How is Vitamin B12 defined?
Vitamin B12 is a nutrient that helps keep the body's nerve and blood cells healthy and helps make DNA, the genetic material in all cells. Vitamin B12 also helps prevent a type of anemia called megaloblastic anemia that makes people tired and weak.In 2025, global Vitamin B12 production reached approximately 148 MT.
What are the main segments of the Vitamin B12 market by type?
By type, the market is segmented into Content 98%, Content 2%, Content 1% and Others.
Which applications drive demand in the Vitamin B12 market?
Key applications covered include Feed Industry, Pharmaceutical Industry, Food Industry, Daily Chemicals and Environmental Protection, Cosmetics and Other.
Who are the key players in the Vitamin B12 market?
Key players profiled include Ouroboros, North China Pharmaceutical Group, Hebei Yufeng, Ningxia Jinwei and Hebei Huarong Pharmaceutical.
Which regions and countries are covered for Vitamin B12?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Vitamin B12 market?
The global vitamin B12 market is growing steadily, driven by a broad expansion in both consumer wellness and clinical nutrition needs.
Who should buy the Vitamin B12 market report?
The report is intended for manufacturers and solution providers, distributors and end users in Feed Industry, Pharmaceutical Industry and Food Industry, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Vitamin B12 market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.